Viking Therapeutics (VKTX) Stock Insights

VKTX price $24.91 +0.02 +0.08%

Ticker
VKTX
Price
$24.91
Change
+0.02 +0.08%
Market cap ?
$3.17B
P/E ?
-5.24
Forward P/E ?
12.21
Dividend yield ?
0.00%
Beta ?
0.65
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
69
Value
60
Quality
48
Growth
100

Stocklytics score rationale: value 60, quality 48, growth 100.

Financials

2016201720182019202020212022202320242025
0000000000

Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting…

Fair value

VKTX fair value $79.92. Price $24.91. Price is 69% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare VKTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-28—-1.06——
2026-07-29-1.10-1.23——
2026-04-29-1.37-1.01——
2026-02-11-1.38-0.89—1.92M
2025-10-22-0.81-0.70——
2025-07-23-0.58-0.44——
2025-04-23-0.41-0.34——
2025-02-05-0.32-0.28——
2024-10-23-0.22-0.24——
2024-07-24-0.20-0.26——
2024-04-24-0.26-0.27——
2024-02-07-0.25-0.25436.00K—
2023-10-25-0.23-0.22——
2023-07-26-0.19-0.21——
2023-04-26-0.25-0.24——
2023-02-08-0.26-0.23——
2022-10-26-0.21-0.23——
2022-07-27-0.23-0.21——
2022-04-27-0.21-0.20——
2022-02-09-0.16-0.19——
2021-11-03-0.17-0.21——
2021-07-28-0.20-0.19——
2021-04-28-0.19-0.18——
2021-02-17-0.15-0.150—
2020-10-28-0.13-0.15—3.15M
2020-07-29-0.13-0.14—3.04M
2020-04-30-0.13-0.12——
2020-02-26-0.10-0.13——
2019-11-05-0.08-0.13——
2019-08-01-0.11-0.09——
2019-05-02-0.07-0.09——
2019-03-13-0.07-0.10——
2018-11-07-0.11-0.11——
2018-08-09-0.13-0.11—1.44M
2018-05-09-0.10-0.11—2.64M
2018-03-07-0.14-0.19—1.69B
2017-11-08-0.22-0.19—1.12B
2017-08-09-0.21-0.19—1.21B
2017-05-10-0.23-0.18—1.06B
2017-03-21-0.18-0.22—1.21B

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-01Kelly-Gemmell Dorothy ElizabethBuy40.80K$31.741.29M
2026-08-01Kelly-Gemmell Dorothy ElizabethBuy6.33K——
2026-08-01Kelly-Gemmell Dorothy ElizabethOther0——
2026-07-29Lian BrianSell148.52K$33.324.95M
2026-07-29ZANTE GREGSell21.22K$33.47710.14K
2026-07-29Mancini MariannaSell18.22K$33.47609.64K
2026-07-28Lian BrianBuy221.67K——
2026-07-28ZANTE GREGBuy31.67K——
2026-07-28Mancini MariannaBuy31.67K——
2026-06-01Chen Hubert CBuy190.00K$31.275.94M
2026-06-01Chen Hubert COther0——
2026-03-10Aubuchon Neil WilliamBuy4.47K$33.50149.91K
2026-01-12Aubuchon Neil WilliamBuy180.00K$31.765.72M
2026-01-12Aubuchon Neil WilliamOther0——
2026-01-05ZANTE GREGSell31.96K$32.301.03M
2026-01-05ZANTE GREGSell13.90K$33.38464.02K
2026-01-05ZANTE GREGSell10.30K$34.24352.63K
2026-01-05ZANTE GREGSell1.50K$32.0948.13K
2026-01-05Mancini MariannaSell31.96K$32.291.03M
2026-01-05Mancini MariannaSell13.60K$33.37453.88K
2026-01-05Mancini MariannaSell10.50K$34.22359.30K
2026-01-05Mancini MariannaSell1.60K$35.0756.12K
2026-01-05Lian BrianSell132.45K$32.294.28M
2026-01-05Lian BrianSell53.28K$33.381.78M
2026-01-05Lian BrianSell41.28K$34.221.41M
2026-01-05Lian BrianSell6.40K$35.07224.42K
2026-01-02ZANTE GREGBuy32.05K——
2026-01-02ZANTE GREGBuy41.00K——
2026-01-02ZANTE GREGBuy91.00K$35.423.22M
2026-01-02Mancini MariannaBuy32.05K——
2026-01-02Mancini MariannaBuy41.00K——
2026-01-02Mancini MariannaBuy91.00K$35.423.22M
2026-01-02Lian BrianBuy224.08K——
2026-01-02Lian BrianBuy78.40K——
2026-01-02Lian BrianBuy176.30K$35.426.24M
2026-01-02SINGLETON J MATTHEWBuy20.40K$35.42722.57K
2026-01-02SINGLETON J MATTHEWBuy3.15K——
2026-01-02MACARTNEY LAWSONBuy3.15K——
2026-01-02MACARTNEY LAWSONBuy20.40K$35.42722.57K
2026-01-02Rowland Charles A JrBuy3.15K——
2026-01-02Rowland Charles A JrBuy20.40K$35.42722.57K
2026-01-02FOEHR MATTHEW WBuy16.00K$3.3353.28K
2026-01-02FOEHR MATTHEW WBuy3.15K——
2026-01-02FOEHR MATTHEW WSell16.00K$35.11561.69K
2026-01-02FOEHR MATTHEW WBuy20.40K$35.42722.57K
2026-01-02FOEHR MATTHEW WSell16.00K$3.3353.28K
2026-01-02Rouan Sarah KathrynBuy20.40K$35.42722.57K
2026-01-02Rouan Sarah KathrynBuy3.15K——
2025-10-28Mancini MariannaSell6.18K$35.00216.49K
2025-10-28Lian BrianSell38.99K$35.011.36M
2025-10-28ZANTE GREGSell6.18K$35.00216.48K
2025-10-27Mancini MariannaBuy11.12K——
2025-10-27Rowland Charles A JrBuy22.00K$4.88107.36K
2025-10-27Rowland Charles A JrBuy22.00K$5.80127.60K
2025-10-27Rowland Charles A JrBuy16.00K$4.4871.68K
2025-10-27Rowland Charles A JrSell60.00K$35.572.13M
2025-10-27Rowland Charles A JrSell22.00K$5.80127.60K
2025-10-27Rowland Charles A JrSell22.00K$4.88107.36K
2025-10-27Rowland Charles A JrSell16.00K$4.4871.68K
2025-10-27Lian BrianBuy70.08K——
2025-10-27ZANTE GREGBuy11.12K——
2025-07-03Lian BrianSell26.89K$27.80747.63K
2025-07-03ZANTE GREGSell4.27K$27.76118.43K
2025-07-03Mancini MariannaSell4.27K$27.77118.47K
2025-07-02Lian BrianBuy48.33K——
2025-07-02ZANTE GREGBuy7.67K——
2025-07-02Mancini MariannaBuy7.67K——
2025-04-11FOEHR MATTHEW WBuy20.79K$8.00166.29K
2025-04-11FOEHR MATTHEW WSell20.79K$8.00166.29K
2025-03-31Rouan Sarah KathrynBuy1.24K$24.1529.94K
2025-01-06Lian BrianSell175.49K$42.687.49M
2025-01-06Lian BrianSell19.00K$43.32823.02K
2025-01-06Mancini MariannaSell49.12K$42.692.10M
2025-01-06Mancini MariannaSell5.10K$43.32220.91K
2025-01-06ZANTE GREGSell45.61K$42.691.95M
2025-01-06ZANTE GREGSell4.70K$43.32203.60K
2025-01-03Lian BrianBuy163.33K——
2025-01-03Lian BrianBuy92.80K——
2025-01-03Lian BrianBuy78.30K$42.893.36M
2025-01-03Mancini MariannaBuy21.67K——
2025-01-03Mancini MariannaBuy44.53K——
2025-01-03Mancini MariannaBuy37.20K$42.891.60M
2025-01-03ZANTE GREGBuy21.67K——
2025-01-03ZANTE GREGBuy44.53K——
2025-01-03ZANTE GREGBuy37.20K$42.891.60M
2025-01-02MACARTNEY LAWSONBuy18.80K$41.12773.06K
2025-01-02SINGLETON J MATTHEWBuy18.80K$41.12773.06K
2025-01-02Rowland Charles A JrBuy18.80K$41.12773.06K
2025-01-02FOEHR MATTHEW WBuy18.80K$41.12773.06K
2025-01-02Rouan Sarah KathrynBuy18.80K$41.12773.06K
2024-11-08MACARTNEY LAWSONBuy2.00K$5.8011.60K
2024-11-08MACARTNEY LAWSONSell2.00K$68.67137.33K
2024-11-08MACARTNEY LAWSONSell2.00K$5.8011.60K
2024-10-28ZANTE GREGBuy51.00K$8.52434.52K
2024-10-28ZANTE GREGSell49.67K$74.563.70M
2024-10-28ZANTE GREGBuy26.00K$5.80150.80K
2024-10-28ZANTE GREGSell18.62K$75.791.41M
2024-10-28ZANTE GREGBuy4.25K$4.6819.89K
2024-10-28ZANTE GREGSell9.27K$76.94712.80K
2024-10-28ZANTE GREGBuy12.75K$7.7799.07K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 471, holders +27 vs prior quarter. Ownership 65.98%.

HolderSharesChangeChange %Value
FMR LLC6.34M311.00K+5.16%247.16M
BLACKROCK, INC.6.19M-690.64K-10.04%241.46M
STATE STREET CORP5.61M1.21M+27.55%218.71M
VANGUARD CAPITAL MANAGEMENT LLC5.05M41.16K+0.82%197.14M
VANGUARD PORTFOLIO MANAGEMENT LLC4.48M19.96K+0.45%174.93M
TWO SIGMA INVESTMENTS, LP3.94M-494.73K-11.16%153.60M
MORGAN STANLEY3.49M472.11K+15.66%135.99M
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.91M2.20M+311.80%113.38M
AMERIPRISE FINANCIAL INC2.16M477.34K+28.43%84.11M
GEODE CAPITAL MANAGEMENT, LLC2.10M15.91K+0.76%81.87M
AMERICAN CENTURY COMPANIES INC1.82M-262.53K-12.63%70.84M
D. E. SHAW & CO., INC.1.61M-70.72K-4.22%62.65M
DIADEMA PARTNERS LP1.22M695.62K+132.45%47.62M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.18M474.39K+67.21%46.04M
CITADEL ADVISORS LLC1.12M693.80K+161.99%43.77M
BNP PARIBAS FINANCIAL MARKETS981.70K441.20K+81.63%38.30M
CITADEL ADVISORS LLC951.51K523.22K+122.16%37.12M
GOLDMAN SACHS GROUP INC942.84K-17.73K-1.85%36.78M
UBS GROUP AG936.05K-411.42K-30.53%36.52M
JPMORGAN CHASE & CO915.18K429.48K+88.42%36.39M
JANE STREET GROUP, LLC899.56K708.46K+370.73%35.09M
SUSQUEHANNA INTERNATIONAL GROUP, LLP816.37K110.56K+15.66%31.85M
RAYMOND JAMES FINANCIAL INC794.66K-1.28M-61.71%31.00M
VANGUARD FIDUCIARY TRUST CO732.05K21.64K+3.05%28.56M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC730.69K-5.78K-0.78%28.50M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Viking Therapeutics (VKTX) Stock Insights

VKTX$24.91+0.02 +0.08%

$3.17B

Market Cap

-5.24

P/E

12.21

Forward P/E

69

Score

Price History